Author Affiliations: WINNER Centre for Newborn Research, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Camperdown (Dr Tarnow-Mordi), Miracle Babies Foundation, Moorebank (Ms Cruz), New South Wales, and Robinson Institute, Discipline of Obstetrics and Gynecology, Women's and Children's Hospital, University of Adelaide, Adelaide, South Australia (Dr Wilkinson), Australia.
The systematic review of randomized controlled trials by Tagin et al in this issue of the Archives1 confirms therapeutic hypothermia, or cooling, as a major advance for infants with hypoxic ischemic encephalopathy (HIE). The evidence, achieved during 2 decades of international collaboration, reflects great credit on the neonatal community, parents, researchers, funding agencies, and providers of health care.
Tarnow-Mordi WO, Cruz M, Wilkinson D. Evaluating Therapeutic HypothermiaParental Perspectives Should Be Explicitly Represented in Future Research. Arch Pediatr Adolesc Med. 2012;166(6):578-579. doi:10.1001/archpediatrics.2012.314